SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000899140-15-000893
Filing Date
2015-12-10
Accepted
2015-12-10 16:59:43
Documents
2
Group Members
TEVA PHARMACEUTICALS USA, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D w15840462a.htm SC 13D 58063
2 JOINT FILING AGREEMENT w15840462b.htm EX-99.1 6071
  Complete submission text file 0000899140-15-000893.txt   65997
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89180 | Film No.: 151281440
SIC: 2834 Pharmaceutical Preparations